Products Categories
CAS No.: | 154-97-2 |
---|---|
Name: | 2-PYRIDINEALDOXIME METHYL METHANESULFONATE |
Article Data: | 4 |
Molecular Structure: | |
Formula: | C7H10N2O•CH3O3S |
Molecular Weight: | 232.26 |
Synonyms: | pralidoximemesilate;PralidoximeMesylate;NMethylpyridinium2aldoximemesylate(Pralidoximemesylate),>98%;PralidoxmeMesylate;Pralidoximemethylsulfate |
Density: | g/cm3 |
Melting Point: | 155° |
Boiling Point: | 189.7°Cat760mmHg |
Flash Point: | 68.5°C |
Safety: | Poison by intraperitoneal, subcutaneous, intravenous, and intramuscular routes. Moderately toxic by ingestion. Human systemic effects by ingestion: gastrointestinal changes; by intravenous route: blood pressure elevation. When heated to decomposition it emits very toxic fumes of NOx and SOx. |
PSA: | 102.05000 |
LogP: | 0.56140 |
What can I do for you?
Get Best Price
Molecule structure of Pralidoxime mesylate (CAS NO.154-97-2):
IUPAC Name: Methanesulfonate; [(E)-(1-methylpyridin-2-ylidene)methyl]-oxoazanium
Molecular Weight: 232.25688 g/mol
Molecular Formula: C8H12N2O4S
H-Bond Donor: 1
H-Bond Acceptor: 5
Rotatable Bond Count: 1
Tautomer Count: 2
Exact Mass: 232.051778
MonoIsotopic Mass: 232.051778
Topological Polar Surface Area: 91.5
Heavy Atom Count: 15
Complexity: 295
Canonical SMILES: CN1C=CC=CC1=C[NH+]=O.CS(=O)(=O)[O-]
Isomeric SMILES: CN\1C=CC=C/C1=C\[NH+]=O.CS(=O)(=O)[O-]
InChI: InChI=1S/C7H8N2O.CH4O3S/c1-9-5-3-2-4-7(9)6-8-10;1-5(2,3)4/h2-6H,1H3;1H3,(H,2,3,4)/b7-6+;
InChIKey: WWZYJJGFUIAWNW-UHDJGPCESA-N
EINECS of Pralidoxime mesylate (CAS NO.154-97-2): 205-839-8
1. | orl-hmn TDLo:52,500 mg/kg/4W-I:GIT | AEHLAU Archives of Environmental Health. 15 (1967),599. | ||
2. | ivn-hmn TDLo:45 mg/kg:CVS | AEHLAU Archives of Environmental Health. 15 (1967),599. | ||
3. | orl-rat LD50:7000 mg/kg | CJBPAZ Canadian Journal of Biochemistry and Physiology. 39 (1961),351. | ||
4. | ipr-rat LD50:262 mg/kg | BJPCAL British Journal of Pharmacology and Chemotherapy. 13 (1958),202. | ||
5. | scu-rat LD50:332 mg/kg | BJPCAL British Journal of Pharmacology and Chemotherapy. 13 (1958),202. | ||
6. | ivn-rat LD50:109 mg/kg | BJPCAL British Journal of Pharmacology and Chemotherapy. 13 (1958),202. | ||
7. | ims-rat LD50:188 µg/kg | BJPCBM British Journal of Pharmacology. 39 (1970),822. | ||
8. | orl-mus LD50:3700 mg/kg | CJBPAZ Canadian Journal of Biochemistry and Physiology. 39 (1961),351. | ||
9. | scu-mus LD50:165 mg/kg | BJPCAL British Journal of Pharmacology and Chemotherapy. 13 (1958),202. | ||
10. | ivn-mus LD50:122 mg/kg | BJPCAL British Journal of Pharmacology and Chemotherapy. 13 (1958),202. |
Poison by intraperitoneal, subcutaneous, intravenous, and intramuscular routes. Moderately toxic by ingestion. Human systemic effects by ingestion: gastrointestinal changes; by intravenous route: blood pressure elevation. When heated to decomposition it emits very toxic fumes of NOx and SOx.
Pralidoxime mesylate (CAS NO.154-97-2) is also named as 1-Methylpyridinium-2-aldoxime methanesulfonate ; 2-Formyl-1-methylpyridinium methanesulfonate oxime ; 2-Formyl-N-methylpyridinium oxime methanesulfonate ; 2-Hydroxyiminomethyl-N-methylpyridinium methanesulfonate ; 2-Hydroxyiminomethyl-N-methylpyridinium methanesulphonate ; 2-Pam methanesulfonate ; Contrathion ; N-Methylpyridinium methane sulfonate 2-aldoxime ; N-Methylpyridinium-2-aldoxime methanesulphonate ; P2S ; Pralidoxime methanesulfonate ; Pralidoxime methosulfate ; Protopam methanesulfonate ; Pyridine-2-aldoxime methyl methane sulfonate ; Pyridinium, 2-((hydroxyimino)methyl)-1-methyl-, methanesulfonate ; Pyridinium, 2-aldoxime, N-methyl methanesulphonate ; UNII-45CO7XIN2K .